A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS – Cardiovascular OutcoMes for People using Anticoagulation Strategies)

Click here for more information.

Register Today!

Trial Information

Start Date2013
End Date2020
Trial DurationUp to 5 years
Number of Visits15
Lead CRCMichael Ricci-Bonzey

For additional information
on this trial contact: